Literature DB >> 28652462

Protective Low-Frequency Variants for Preeclampsia in the Fms Related Tyrosine Kinase 1 Gene in the Finnish Population.

A Inkeri Lokki1, Emma Daly2, Michael Triebwasser2, Mitja I Kurki2, Elisha D O Roberson2, Paavo Häppölä2, Kirsi Auro2, Markus Perola2, Seppo Heinonen2, Eero Kajantie2, Juha Kere2, Katja Kivinen2, Anneli Pouta2, Jane E Salmon2, Seppo Meri2, Mark Daly2, John P Atkinson2, Hannele Laivuori1.   

Abstract

Preeclampsia is a common pregnancy-specific vascular disorder characterized by new-onset hypertension and proteinuria during the second half of pregnancy. Predisposition to preeclampsia is in part heritable. It is associated with an increased risk of cardiovascular disease later in life. We have sequenced 124 candidate genes implicated in preeclampsia to pinpoint genetic variants contributing to predisposition to or protection from preeclampsia. First, targeted exomic sequencing was performed in 500 preeclamptic women and 190 controls from the FINNPEC cohort (Finnish Genetics of Preeclampsia Consortium). Then 122 women with a history of preeclampsia and 1905 parous women with no such history from the National FINRISK Study (a large Finnish population survey on risk factors of chronic, noncommunicable diseases) were included in the analyses. We tested 146 rare and low-frequency variants and found an excess (observed 13 versus expected 7.3) nominally associated with preeclampsia (P<0.05). The most significantly associated sequence variants were protective variants rs35832528 (E982A; P=2.49E-4; odds ratio=0.387) and rs141440705 (R54S; P=0.003; odds ratio=0.442) in Fms related tyrosine kinase 1. These variants are enriched in the Finnish population with minor allele frequencies 0.026 and 0.017, respectively. They may also be associated with a lower risk of heart failure in 11 257 FINRISK women. This study provides the first evidence of maternal protective genetic variants in preeclampsia.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  Finland; cardiovascular diseases; heart failure; preeclampsia; proteinuria

Mesh:

Substances:

Year:  2017        PMID: 28652462      PMCID: PMC5535812          DOI: 10.1161/HYPERTENSIONAHA.117.09406

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  38 in total

Review 1.  Immunology of pre-eclampsia.

Authors:  Christopher W G Redman; Ian L Sargent
Journal:  Am J Reprod Immunol       Date:  2010-03-23       Impact factor: 3.886

2.  Incidence of preeclampsia: risk factors and outcomes associated with early- versus late-onset disease.

Authors:  Sarka Lisonkova; K S Joseph
Journal:  Am J Obstet Gynecol       Date:  2013-08-22       Impact factor: 8.661

3.  Inching towards a targeted therapy for preeclampsia.

Authors:  Ravi Thadhani
Journal:  Hypertension       Date:  2009-12-21       Impact factor: 10.190

4.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

5.  The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1.

Authors:  Hans W Christinger; Germaine Fuh; Abraham M de Vos; Christian Wiesmann
Journal:  J Biol Chem       Date:  2003-12-18       Impact factor: 5.157

6.  Usefulness of soluble Fms-like tyrosine kinase-1 as a biomarker of acute severe heart failure in patients with acute myocardial infarction.

Authors:  Kenji Onoue; Shiro Uemura; Yukiji Takeda; Satoshi Somekawa; Hajime Iwama; Taku Nishida; Yoshinobu Morikawa; Hitoshi Nakagawa; Takeshi Tsutsumi; Ji Hee Sung; Yasuhiro Takemoto; Tsunenari Soeda; Satoshi Okayama; Kenichi Ishigami; Hiroyuki Kawata; Manabu Horii; Tamio Nakajima; Yoshihiko Saito
Journal:  Am J Cardiol       Date:  2009-12-01       Impact factor: 2.778

Review 7.  Pregnancy and Long-Term Maternal Cardiovascular Health: Progress Through Harmonization of Research Cohorts and Biobanks.

Authors:  Anne Cathrine Staff; Christopher W G Redman; David Williams; Paul Leeson; Kjartan Moe; Basky Thilaganathan; Per Magnus; Eric A P Steegers; Eleni Z Tsigas; Roberta B Ness; Leslie Myatt; Lucilla Poston; James M Roberts
Journal:  Hypertension       Date:  2015-12-14       Impact factor: 10.190

8.  Highly significant association between two common single nucleotide polymorphisms in CORIN gene and preeclampsia in Caucasian women.

Authors:  Alain Stepanian; Alexandre Alcaïs; Dominique de Prost; Vassilis Tsatsaris; Michel Dreyfus; Jean-Marc Treluyer; Laurent Mandelbrot
Journal:  PLoS One       Date:  2014-12-04       Impact factor: 3.240

9.  An integrated map of genetic variation from 1,092 human genomes.

Authors:  Goncalo R Abecasis; Adam Auton; Lisa D Brooks; Mark A DePristo; Richard M Durbin; Robert E Handsaker; Hyun Min Kang; Gabor T Marth; Gil A McVean
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Distribution and medical impact of loss-of-function variants in the Finnish founder population.

Authors:  Elaine T Lim; Peter Würtz; Aki S Havulinna; Priit Palta; Taru Tukiainen; Karola Rehnström; Tõnu Esko; Reedik Mägi; Michael Inouye; Tuuli Lappalainen; Yingleong Chan; Rany M Salem; Monkol Lek; Jason Flannick; Xueling Sim; Alisa Manning; Claes Ladenvall; Suzannah Bumpstead; Eija Hämäläinen; Kristiina Aalto; Mikael Maksimow; Marko Salmi; Stefan Blankenberg; Diego Ardissino; Svati Shah; Benjamin Horne; Ruth McPherson; Gerald K Hovingh; Muredach P Reilly; Hugh Watkins; Anuj Goel; Martin Farrall; Domenico Girelli; Alex P Reiner; Nathan O Stitziel; Sekar Kathiresan; Stacey Gabriel; Jeffrey C Barrett; Terho Lehtimäki; Markku Laakso; Leif Groop; Jaakko Kaprio; Markus Perola; Mark I McCarthy; Michael Boehnke; David M Altshuler; Cecilia M Lindgren; Joel N Hirschhorn; Andres Metspalu; Nelson B Freimer; Tanja Zeller; Sirpa Jalkanen; Seppo Koskinen; Olli Raitakari; Richard Durbin; Daniel G MacArthur; Veikko Salomaa; Samuli Ripatti; Mark J Daly; Aarno Palotie
Journal:  PLoS Genet       Date:  2014-07-31       Impact factor: 5.917

View more
  5 in total

1.  Integrated Systems Biology Approach Identifies Novel Maternal and Placental Pathways of Preeclampsia.

Authors:  Nandor Gabor Than; Roberto Romero; Adi Laurentiu Tarca; Katalin Adrienna Kekesi; Yi Xu; Zhonghui Xu; Kata Juhasz; Gaurav Bhatti; Ron Joshua Leavitt; Zsolt Gelencser; Janos Palhalmi; Tzu Hung Chung; Balazs Andras Gyorffy; Laszlo Orosz; Amanda Demeter; Anett Szecsi; Eva Hunyadi-Gulyas; Zsuzsanna Darula; Attila Simor; Katalin Eder; Szilvia Szabo; Vanessa Topping; Haidy El-Azzamy; Christopher LaJeunesse; Andrea Balogh; Gabor Szalai; Susan Land; Olga Torok; Zhong Dong; Ilona Kovalszky; Andras Falus; Hamutal Meiri; Sorin Draghici; Sonia S Hassan; Tinnakorn Chaiworapongsa; Manuel Krispin; Martin Knöfler; Offer Erez; Graham J Burton; Chong Jai Kim; Gabor Juhasz; Zoltan Papp
Journal:  Front Immunol       Date:  2018-08-08       Impact factor: 7.561

2.  Dysfunction of complement receptors CR3 (CD11b/18) and CR4 (CD11c/18) in pre-eclampsia: a genetic and functional study.

Authors:  A I Lokki; L Teirilä; M Triebwasser; E Daly; A Bhattacharjee; L Uotila; M Llort Asens; M I Kurki; M Perola; K Auro; J E Salmon; M Daly; J P Atkinson; H Laivuori; S Fagerholm; S Meri
Journal:  BJOG       Date:  2021-03-14       Impact factor: 7.331

Review 3.  Cardiovascular System in Preeclampsia and Beyond.

Authors:  Basky Thilaganathan; Erkan Kalafat
Journal:  Hypertension       Date:  2019-03       Impact factor: 10.190

4.  Modelling preeclampsia: a comparative analysis of the common human trophoblast cell lines.

Authors:  Jiawu Zhao; Rebecca P Chow; Rebecca H McLeese; Michelle B Hookham; Timothy J Lyons; Jeremy Y Yu
Journal:  FASEB Bioadv       Date:  2020-11-21

Review 5.  The Immunogenetic Conundrum of Preeclampsia.

Authors:  A Inkeri Lokki; Jenni K Heikkinen-Eloranta; Hannele Laivuori
Journal:  Front Immunol       Date:  2018-11-13       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.